Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Shelli R, Kesler"'
Autor:
Shelli R. Kesler, Oscar Y. Franco-Rocha, Alexa De La Torre Schutz, Kimberly A. Lewis, Rija M. Aziz, Ashley M. Henneghan, Esther Melamed, W. Michael Brode
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract COVID-19 is associated with increased risk for cognitive decline but very little is known regarding the neural mechanisms of this risk. We enrolled 49 adults (55% female, mean age = 30.7 ± 8.7), 25 with and 24 without a history of COVID-19
Externí odkaz:
https://doaj.org/article/b0dfab4e8d6e42368600e764888e136c
Autor:
Michele M. Mulholland, Alexa Stuifbergen, Alexa De La Torre Schutz, Oscar Y. Franco Rocha, Douglas W. Blayney, Shelli R. Kesler
Publikováno v:
Frontiers in Aging Neuroscience, Vol 16 (2024)
IntroductionChemotherapy-related cognitive impairment (CRCI) remains poorly understood in terms of the mechanisms of cognitive decline. Neural hyperactivity has been reported on average in cancer survivors, but it is unclear which patients demonstrat
Externí odkaz:
https://doaj.org/article/d0b60d359cbb4d9989f4dab22bf459ad
Autor:
Shelli R. Kesler, Rebecca A. Harrison, Alexa De La Torre Schutz, Hayley Michener, Paris Bean, Veronica Vallone, Sarah Prinsloo
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionLike other forms of neuropathology, gliomas appear to spread along neural pathways. Accordingly, our group and others have previously shown that brain network connectivity is highly predictive of glioma survival. In this study, we aimed t
Externí odkaz:
https://doaj.org/article/69501d91af0049398119f3da94e17c18
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 6068-6076 (2023)
Abstract Background Cognitive impairment is a frequent adverse effect of cancer and its therapies. As neuropsychological assessment is not often standard of care for patients with non‐CNS disease, efficient, practical assessment tools are required
Externí odkaz:
https://doaj.org/article/e237992df9984bed835e8cc620f3279b
Autor:
Shelli R. Kesler, Rebecca A. Harrison, Vikram Rao, Hannah Dyson, Melissa Petersen, Sarah Prinsloo
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Diffuse gliomas are incurable brain tumors, yet there is significant heterogeneity in patient survival. Advanced computational techniques such as radiomics show potential for presurgical prediction of survival and other outcomes from neuroim
Externí odkaz:
https://doaj.org/article/95c7ca02d26b449aac4e4b1cab80c10a
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Cancer related cognitive impairment (CRCI) is commonly associated with cancer and its treatments, yet the present binary diagnostic approach fails to capture the full spectrum of this syndrome. Cognitive function is highly complex and exists on a con
Externí odkaz:
https://doaj.org/article/521db162b15e4a389b788117d885b9b0
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Genetic polymorphisms in select genes, including APOE (apolipoprotein E), COMT (Catechol-O-Methyltransferase), MDR1 (multi-drug resistance 1), BDNF (brain derived neurotrophic factor), and GST (glutathione-S-transferase), have been associate
Externí odkaz:
https://doaj.org/article/37562c0090cf45708aa62584b1167008
Publikováno v:
JMIR Cancer, Vol 8, Iss 2, p e34828 (2022)
BackgroundCancer-related cognitive impairment (CRCI) is a common and significant adverse effect of cancer and its therapies. However, its definition and assessment remain difficult due to limitations of currently available measurement tools. Objecti
Externí odkaz:
https://doaj.org/article/033216510060418f9537d536c49ac7e7
Autor:
Valerie Danesh, PhD, Leanne M. Boehm, PhD, Tammy L. Eaton, PhD, Alejandro C. Arroliga, MD, Kirby P. Mayer, PhD, Shelli R. Kesler, PhD, Rita N. Bakhru, MD, Michael Baram, MD, Amy L. Bellinghausen, MD, Michelle Biehl, MD, Neha S. Dangayach, MD, Nir M. Goldstein, MD, K. Sarah Hoehn, MD, Marjan Islam, MD, Sugeet Jagpal, MD, Annie B. Johnson, APRN, Sarah E. Jolley, MD, Janet A. Kloos, PhD, Eric J. Mahoney, MD, Jason H. Maley, MD, Sara F. Martin, MD, Jakob I. McSparron, MD, Marissa Mery, MD, Howard Saft, MD, Lekshmi Santhosh, MD, Kristin Schwab, MD, Dario Villalba, PT, Carla M. Sevin, MD, Ashley A. Montgomery, MD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 3, p e0658 (2022)
OBJECTIVES:. The multifaceted long-term impairments resulting from critical illness and COVID-19 require interdisciplinary management approaches in the recovery phase of illness. Operational insights into the structure and process of recovery clinics
Externí odkaz:
https://doaj.org/article/e73ca6057b3a4d2a8079617ae0296c7c
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
ImportancePrevious studies of post-acute COVID-19 syndrome have focused on critical cases with severe disease. However, most cases are mild to moderate in disease severity.ObjectiveWe aimed to examine cognitive outcomes in cases of non-critical, mild
Externí odkaz:
https://doaj.org/article/581c4df4c7da4f2c9bd8c962f9afe239